The DOI matches its Crossref record.
Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin
Abstract
It is commonly accepted that melatonin (N-acetyl-5-methoxytryptamine), the most relevant pineal secretory product, has oncostatic properties in a wide variety of tumors and, especially, in those identified as being hormone-dependent. The objective of the present article is to offer a global and integrative view of the mechanisms involved in the oncostatic actions of this indoleamine. Due to the wide spectrum of melatonins actions, the mechanisms that may be involved in its ability to counteract tumor growth are varied. These include: a) antioxidant effects; b) regulation of the estrogen receptor expression and transactivation; c) modulation of the enzymes involved in the local synthesis of estrogens; d) modulation of cell cycle and induction of apoptosis; e) inhibition of telomerase activity; f) inhibition of metastasis; g) prevention of circadian disruption; h) antiangiogenesis; i) epigenetic effects; j) stimulation of cell differentiation; and k) activation of the immune system. The data supporting each of these oncostatic actions of melatonin are summarized in this review. Moreover, the list of actions described may not be exhaustive in terms of how melatonin modulates tumor growth. Keywords: Melatonin, cancer, antioxidant, immunoenhancing, estrogen signalling pathway, angiogenesis, telomerase, metastasis, epigenetic effects, indoleamine, malignant tumors, Neuroendocrin, neoplastic diseases, malignant neoplasias, sarcomas, colorectal cancer, hepatocarcinomas, melanoma, neural tumors, larynx carcinomas, cervical cancer, estrogenic receptor, mitogenic proteins, calmodulin (CaM), osteoblasts, aortic smooth muscle, antiaromatases, anastroxole, exemestrane, letrozole, estrogen sulfotransferases, mesenchymal stem cells, cytodifferentiating effects, cytosolic proteases, apoptotic induced factor, vincristine, ifosfamide, telomerase activity, xenoestrogens, reactive oxygen species, carbonic anhydrase IX, suprachiasmatic nuclei, E-cadherin, 1-integrin, lymphoid organs, lymphocytes, pinealectomy, epidermal growth factor receptor (EGFR), mitogenactivated protein kinase (MAPK), 13-hydroxyoctadecadienoic acid, neuroendocrine-reproductive, neoplasias
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Melatonin: a well‐documented antioxidant with conditional pro‐oxidant actions
Zhang, H., & Zhang, Y. (2014) · Journal of Pineal Research · doi:10.1111/jpi.12162 · Cited by 813
Touitou, Y., Reinberg, A., & Touitou, D. (2017) · Life Sciences · doi:10.1016/j.lfs.2017.02.008 · Cited by 738
Melatonin, a Full Service Anti-Cancer Agent: Inhibition of Initiation, Progression and Metastasis
Reiter, R., Rosales-Corral, S., Tan, D.-X., Acuna-Castroviejo, D., Qin, L., Yang, S.-F., & Xu, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040843 · Cited by 433
Pandi-Perumal, S. R., BaHammam, A. S., Brown, G. M., Spence, D. W., Bharti, V. K., Kaur, C., Hardeland, R., & Cardinali, D. P. (2013) · Neurotoxicity Research · doi:10.1007/s12640-012-9337-4 · Cited by 320
Melatonin: an inhibitor of breast cancer
Hill, S. M., Belancio, V. P., Dauchy, R. T., Xiang, S., Brimer, S., Mao, L., Hauch, A., Lundberg, P. W., Summers, W., Yuan, L., et al. (2015) · Endocrine-Related Cancer · doi:10.1530/erc-15-0030 · Cited by 317
Metadata
- Authors
- D. Mediavilla, M., J. Sanchez-Barcelo, E., X. Tan, D., Manchester, L., & J. Reiter, R.
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-12-01
- Volume
- 17
- Issue
- 36
- Pages
- 4462-4481
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2148895922
- Cited by
- 234
- References
- 0
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin. https://app.cochat.ai/papers/10.2174/092986710794183015
- The paper
- D. Mediavilla, M., J. Sanchez-Barcelo, E., X. Tan, D., Manchester, L., & J. Reiter, R. (2010). Basic Mechanisms Involved in the Anti-Cancer Effects of Melatonin. Current Medicinal Chemistry. https://doi.org/10.2174/092986710794183015
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.